Yervoy® (ipilimumab) – Expanded indication
July 24, 2017 – Bristol-Myers Squibb announced the FDA approval of Yervoy (ipilimumab), for the treatment of unresectable or metastatic melanoma in adults and pediatric patients (12 years and older).
Download PDF
